The efficacy and safety of ZR2 versus R-CHOP-like for elderly patients with newly diagnosed diffuse large B cell lymphoma: a single-center prospective study in China.

导出 LinkOut

翻译打印收藏纠错

作者： Panruo,Jiang ^[1] ; Rongqi,Li ^[2] ; Hui,Li ^[3] ; Yilan,Xu ^[3] ; Zhenyan,Xu ^[3] ; Chongyun,Xing ^[3] ; Kang,Yu ^[3] ; Songfu,Jiang ^[4] ; Xiuhua,Zhang ^[5] ; Haige,Ye ^[6]

作者单位： Department of Hematology, Dongyang People's Hospital, Jinhua, Zhejiang, China. ^[1] Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. ^[2] Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. ^[3] Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. jsongfu@163.com. ^[4] Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Wzzhangxiuhua@126.com. ^[5] Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. haigeye@wzhospital.cn. ^[6]

关键词 Elderly patient Lenalidomide Newly diagnosed diffuse large B-cell lymphoma Zanubrutinib

DOI 10.1007/s00277-024-06066-3

PMID 39472318

发布时间 2024-10-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Annals of hematology

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The efficacy and safety of ZR2 versus R-CHOP-like for elderly patients with newly diagnosed diffuse large B cell lymphoma: a single-center prospective study in China.

Annals of hematology

相似文献

Annals of hematology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The efficacy and safety of ZR2 versus R-CHOP-like for elderly patients with newly diagnosed diffuse large B cell lymphoma: a single-center prospective study in China.

Annals of hematology

相似文献

Annals of hematology

相关期刊

检索历史清除